A surge in pharmaceutical shares and a retreat in Brent crude helped major US indexes extend their recovery amid a heavy corporate earnings slate.
A 41% surge in equity trading to $5.8 billion offset weaker performance in fixed income and deal underwriting.
Soaring investor demand and volatile prices have turned precious metals into a multi-billion-dollar gold rush for major trading desks.
A reported $20 billion gap in the AI giant's annualised figures shook Wall Street, compounding fears over rising interest rates.
Major US stock exchanges will launch overnight sessions, but institutional investors remain deeply skeptical about low liquidity and high volatility.
Surging borrowing costs and rising crude prices compound inflation fears ahead of the Federal Reserve's interest rate decision.
